Fetal chronic hypoxia does not affect urinary presepsin levels in newborns at birth
- PMID: 38353160
- DOI: 10.1515/cclm-2023-1308
Fetal chronic hypoxia does not affect urinary presepsin levels in newborns at birth
Abstract
Objectives: Early sepsis detection and diagnosis still constitutes an open issue since the accuracy of standard-of care parameters is biased by a series of perinatal factors including hypoxia. Therefore, we aimed at investigating the effect of fetal chronic hypoxia insult on urine levels of a promising new marker of sepsis, namely presepsin (P-SEP).
Methods: We conducted a prospective case-control study in 22 cases of early-intrauterine growth restriction (E-IUGR) compared with 22 small-for-gestational-age (SGA) newborns and 66 healthy controls. P-SEP urine samples were collected over the first 72 h from birth. Blood culture and C-reactive protein (CRP) blood levels were measured in E-IUGR and SGA infants. Perinatal standard monitoring parameters and main outcomes were also recorded.
Results: No significant urinary P-SEP differences (p>0.05, for all) were observed among studied groups. Moreover, no significant correlations (p>0.05, for both) between urinary P-SEP and blood CRP levels in both E-IUGR and SGA groups (R=0.08; R=0.07, respectively) were observed.
Conclusions: The present results showing the lack of influence of fetal chronic hypoxia on urinary P-SEP levels offer additional data to hypothesize the possible use of urinary P-SEP measurement in neonates in daily clinical practice. Further multicenter prospective data are needed, including infants with early-onset sepsis.
Keywords: hypoxia; intrauterine growth retardation; newborns; presepsin.
© 2024 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Deshmukh, M, Mehta, S, Patole, S. Sepsis calculator for neonatal early onset sepsis – a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2021;34:1832–40. https://doi.org/10.1080/14767058.2019.1649650 . - DOI
-
- Botondi, V, D’Adamo, E, Plebani, M, Trubiani, O, Perrotta, M, Di Ricco, L, et al.. Perinatal presepsin assessment: a new sepsis diagnostic tool? Clin Chem Lab Med 2022;60:1136–44. https://doi.org/10.1515/cclm-2022-0277 . - DOI
-
- van Maldeghem, I, Nusman, CM, Visser, DH. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis. BMC Immunol 2019;20:17. https://doi.org/10.1186/s12865-019-0298-8 . - DOI
-
- Pugni, L, Pietrasanta, C, Milani, S, Vener, C, Ronchi, A, Falbo, M, et al.. Presepsin (Soluble CD14 Subtype): reference ranges of a new sepsis marker in term and preterm neonates. PLoS One 2015;10:e0146020. https://doi.org/10.1371/journal.pone.0146020 . - DOI
-
- Mussap, M, Puxeddu, E, Burrai, P, Noto, A, Cibecchini, F, Testa, M, et al.. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. J Matern Neonatal Med 2012;25:51–3. https://doi.org/10.3109/14767058.2012.717462 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous